• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Study: Merit increase budgets continue to rise in the global CRO industry

Study: Merit increase budgets continue to rise in the global CRO industry

March 19, 2015
CenterWatch Staff

Merit increase budgets continue to rise in the global CRO industry, according to a study conducted by HR+Survey Solutions. The survey found the overall global (all countries combined) average budgeted salary increase for 2015 is 4.14%, up from 3.94% in 2014, and significantly higher than the overall average actual increase in 2014 of 3.7%.

The survey also found:

  • On average, companies actual 2014 merit increases were 0.25 percentage points less than budgeted
  • Hong Kong had the largest gap between actual and budgeted in 2014, with the average actual merit increase 0.85 percentage points below budgeted
  • Argentina had the biggest increase between budgeted and actual in 2014, with actual merit increase averaging 0.65 percentage points above budgeted
  • Belgium had the lowest actual merit increase in 2014 at 1.7%.

The 2014-2015 CRO Industry Global Salary Planning Survey, conducted by HR+Survey Solutions, a specialty compensation consulting and research firm, provides industry compensation professionals with a clear picture of how salaries are increasing against planned budgets across the globe. Professionals utilize these data to keep abreast of trends in rapidly expanding employment markets.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing